The World Health Organization (WHO) – which has made the development of a Shigella vaccine one of its top global health priorities – has estimated that up to 165 million cases of shigellosis ...

Shigella bacteria causes fever, diarrhoea and stomach pain. Since 2015, officials have noted a rise in cases linked to the drug-resistant strain. The inability to treat infections with medication ...

In a first step, the vaccine dose will be confirmed and, in a second step, participants will be challenged with the Shigella sonnei strain 53G one month after injection of S4V2 or placebo ...

The Johns Hopkins Center for Immunization Research is looking for healthy volunteers to participate in an inpatient shigella vaccine study. The study has both an outpatient and inpatient portion. The ...

A recent study published in Clinical Infectious Diseases has uncovered an increase in severe multidrug-resistant (MDR) ...

This includes the only Lyme disease vaccine candidate in advanced clinical development, which is partnered with Pfizer, the world’s most clinically advanced Shigella vaccine candidate ...

In a first step, the vaccine dose will be confirmed and, in a second step, participants will be challenged with the Shigella sonnei strain 53G one month after injection of S4V2 or placebo, in order to ...